Young Houston Emergency Opioid Engagement System
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · Mar 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Young Houston Emergency Opioid Engagement System (Young HEROES) is a clinical trial aimed at helping young people who are struggling with opioid use, such as those who might be dependent on or have overdosed on these drugs. This program is designed to provide comprehensive support through outreach, medication, counseling, and peer support to see how effective these methods are in helping youths engage with and stick to their treatment. Researchers are also looking to understand how common opioid overdoses and related issues are among young people in Houston.
To be eligible for the trial, participants should be generally healthy and willing to quit using opioids. They must also have a positive drug test for opioids and be able to speak English. Importantly, minors will need permission from a parent or guardian to participate. If you join the study, you can expect to receive personalized support and resources to help you on your journey to recovery. This trial is currently recruiting participants, and it aims to make a real difference in the lives of young people dealing with opioid challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • In otherwise good health based on physician assessment and medical history
- • Drug screen positive for opioids
- • Patients express a willingness to stop opioid use
- • Meet Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM-IV-TR) criteria for opioid dependence
- • Patients must be able to speak English
- • Be agreeable to and capable of signing the informed consent and assent (parent or guardian must consent, minor must assent)
- Exclusion Criteria:
- • Non-English-speaking patients
- • Have a known sensitivity to buprenorphine or naloxone
- • Be physiologically dependent on alcohol, benzodiazepines, or other drugs of abuse that require immediate medical attention. Other substance use diagnoses are not exclusionary.
- • Have a medical condition that would, in the opinion of the study physician, make participation medically hazardous, including unstable cardiovascular disease, neurological deficits, trauma, acute hepatitis, stroke, and liver or renal disease)
- • Be acutely psychotic, severely depressed, and in need of inpatient treatment, or is an immediate suicide risk
- • Be a nursing or pregnant female
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
James R Langabeer, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials